Rabia Gurses Ozden
CIK 1814883 · Chief Medical Officer · last filed 2025-12-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.37M
Companies
2
Total Filings
13
Lifetime Open-Market Net
-$38.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Chief Medical Officer | 0 | $4.36 | $0 | $0 | 7 | 2025-12-10 |
| OCUL | Chief Medical Officer | 153,054 | $8.94 | $1.37M | -$38.9K | 6 | 2024-02-06 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-01 | OCUL | Grant (A) | +55,556 | $0 | EDGAR |
| 2022-07-15 | OCUL | Grant (A) | +6,667 | $0 | EDGAR |
| 2022-03-18 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.